Rcadia Closes $3.3 Million Investment Led by BioVentures

 
December 16, 2008

December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.

The COR Analyzer is designed to enable rapid triage of chest pain patients. Immediately after a Coronary CTA study, the COR Analayzer identifies patients who need further evaluation for severe coronary artery disease, versus those who can be safely discharged. While improving emergency department (ED) workflow, the Rcadia application also can lead to more rapid diagnosis, enabling appropriate treatments and avoiding unnecessary delays for patients without coronary artery disease.

For more information: www.rcadia.com

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Combined Holter Records Both ECG, Blood Pressure

April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter and ambulatory blood pressure monitoring recorder and software analysis...

Advanced Visualization Adds 5D Functional Analytics Using Supercomputing Algorithms

March 12, 2010 – A new advanced visualization technology in development allows clinicians to automatically apply supercomputing algorithms for the analysis of internal organs, vessels, tumors and...

New Clinical Studies Support Broader Use of CardioNet System for the Detection of Atrial Fibrillation

January 9, 2009 - CardioNet Inc. today announced the publication of two studies and the presentation of two abstracts that further support the broader use of the CardioNet System for the detection...

View all